These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 16537689)

  • 21. Quality of life after radical prostatectomy in Japanese men: 2 year longitudinal study.
    Namiki S; Saito S; Satoh M; Ishidoya S; Kawamura S; Tochigi T; Kuwahara M; Aizawa M; Ioritani N; Yoshimura K; Ichioka K; Terai A; Arai Y
    Jpn J Clin Oncol; 2005 Sep; 35(9):551-8. PubMed ID: 16141296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health related quality of life patterns in patients treated with interstitial prostate brachytherapy for localized prostate cancer--data from CaPSURE.
    Downs TM; Sadetsky N; Pasta DJ; Grossfeld GD; Kane CJ; Mehta SS; Carroll PR; Lubeck DP
    J Urol; 2003 Nov; 170(5):1822-7. PubMed ID: 14532784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of hormonal therapy prior to radical prostatectomy on the recovery of quality of life.
    Namiki S; Saito S; Tochigi T; Kuwahara M; Ioritani N; Yoshimura K; Terai A; Koinuma N; Arai Y
    Int J Urol; 2005 Feb; 12(2):173-81. PubMed ID: 15733112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promising long-term health-related quality of life after high-dose-rate brachytherapy boost for localized prostate cancer.
    Wahlgren T; Nilsson S; Lennernäs B; Brandberg Y
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):662-70. PubMed ID: 17499452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recovery of quality of life in year after laparoscopic or retropubic radical prostatectomy: a multi-institutional longitudinal study.
    Namiki S; Egawa S; Baba S; Terachi T; Usui Y; Terai A; Tochigi T; Kuwahara M; Ioritani N; Arai Y
    Urology; 2005 Mar; 65(3):517-23. PubMed ID: 15780368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health-related quality-of-life outcomes following IMRT versus conventional radiotherapy for oropharyngeal squamous cell carcinoma.
    Yao M; Karnell LH; Funk GF; Lu H; Dornfeld K; Buatti JM
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1354-60. PubMed ID: 17689885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Obesity does not adversely affect health-related quality-of-life outcomes after anatomic retropubic radical prostatectomy.
    Freedland SJ; Haffner MC; Landis PK; Saigal CS; Carter HB
    Urology; 2005 Jun; 65(6):1131-6. PubMed ID: 15913722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality of life of patients with prostate cancer treated with surgery or radiation therapy.
    Yarbro CH; Ferrans CE
    Oncol Nurs Forum; 1998 May; 25(4):685-93. PubMed ID: 9599352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radical prostatectomy versus high-dose rate brachytherapy for prostate cancer: effects on health-related quality of life.
    Jo Y; Junichi H; Tomohiro F; Yoshinari I; Masato F
    BJU Int; 2005 Jul; 96(1):43-7. PubMed ID: 15963118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective longitudinal study comparing the impact of external radiation therapy with radical prostatectomy on health related quality of life (HRQOL) in prostate cancer patients.
    van Andel G; Visser AP; Zwinderman AH; Hulshof MC; Horenblas S; Kurth KH
    Prostate; 2004 Mar; 58(4):354-65. PubMed ID: 14968436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy.
    Miller DC; Sanda MG; Dunn RL; Montie JE; Pimentel H; Sandler HM; McLaughlin WP; Wei JT
    J Clin Oncol; 2005 Apr; 23(12):2772-80. PubMed ID: 15837992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer.
    Frank SJ; Pisters LL; Davis J; Lee AK; Bassett R; Kuban DA
    J Urol; 2007 Jun; 177(6):2151-6; discussion 2156. PubMed ID: 17509305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer.
    Vora SA; Wong WW; Schild SE; Ezzell GA; Halyard MY
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1053-8. PubMed ID: 17398023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No impairment of quality of life 18 months after high-dose intensity-modulated radiotherapy for localized prostate cancer: a prospective study.
    Marchand V; Bourdin S; Charbonnel C; Rio E; Munos C; Campion L; Bonnaud-Antignac A; Lisbona A; Mahé MA; Supiot S
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1053-9. PubMed ID: 19880259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer.
    Wang-Chesebro A; Xia P; Coleman J; Akazawa C; Roach M
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):654-62. PubMed ID: 17011444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 10-year survival and quality of life in patients with high-risk pN0 prostate cancer following definitive radiotherapy.
    Berg A; Lilleby W; Bruland OS; Fosså SD
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1074-83. PubMed ID: 17703896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychological distress in Japanese men with localized prostate cancer.
    Namiki S; Saito S; Tochigi T; Numata I; Ioritani N; Arai Y
    Int J Urol; 2007 Oct; 14(10):924-9. PubMed ID: 17880290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health-related quality of life in men after treatment of localized prostate cancer with external beam radiotherapy combined with (192)ir brachytherapy: a prospective study of 93 cases using the EORTC questionnaires QLQ-C30 and QLQ-PR25.
    Wahlgren T; Brandberg Y; Häggarth L; Hellström M; Nilsson S
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):51-9. PubMed ID: 15337539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality-of-life outcomes for men with prostate carcinoma detected by screening.
    Smith DS; Carvalhal GF; Schneider K; Krygiel J; Yan Y; Catalona WJ
    Cancer; 2000 Mar; 88(6):1454-63. PubMed ID: 10717630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer.
    Gore JL; Kwan L; Lee SP; Reiter RE; Litwin MS
    J Natl Cancer Inst; 2009 Jun; 101(12):888-92. PubMed ID: 19509365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.